Fosterville South Expl Ltd (FSXLF)
$2.50 0.00 (0.00%)
15:58 EDT FSXLF Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 59,300
Day's Range 2.46 - 2.73
52-Week Range 0.95 - 3.89
Dividend & Yield N/A (N/A)
FSXLF Stock Predictions, Articles, and Fosterville South Expl Ltd News
- From InvestorPlace
- From the Web
While people can take some encouragement from declining coronavirus cases, the economy is still standing on shaky ground. Thus, the narrative for gold stocks to buy is as strong as ever.
Penny stocks will always be risky. That said, with the huge disconnect we’re seeing in the markets, now may be a time to gamble.
Arrowhead Pharmaceuticals, Myomo leads healthcare gainers, Novus Therapeutics, Jounce Therapeutics among major losers
From Seeking Alpha
Gainers: Arrowhead Pharmaceuticals (NASDAQ:ARWR) +46%, Myomo (NYSEMKT:MYO) +38%, AxoGen (NASDAQ:AXGN) +15%, Covetrus (NASDAQ:CVET) +14%, Inovio Pharmaceuticals (NASDAQ:INO) +13%.Losers: Novus Therapeutics (NASDAQ:NVUS) -13%, Jounce Therapeutics (NASDAQ:JNCE) -10%, Syneos Health (NASDAQ:SYNH) -7%, Verastem (NASDAQ:VSTM) -5%, Evogene (NASDAQ:EVGN) -5%.
From Seeking Alpha
AxoGen (NASDAQ:AXGN) shares spike +23% after hours following the announcement of higher revenue guidance for third quarter.The company says it now expects Q3 revenue to be "at least" $30M, above the market estimate of $23.04M. AxoGen initially expected its Q3 revenue to remain below the prior-year levels of $28.6M.Upside on quarterly revenue guidance points to the lower than expected impact of regional COVID-19 resurgence on the incidence of trauma and surgical procedure, told AxoGen.
From Market News Video
Investors in Axogen Inc (AXGN) saw new options begin trading this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AXGN options chain for the new September 18th contracts and identified one put and one call contract of particular interest.